1	High-grade	High-grade	B-NP	JJ	O	6	NMOD	-1
2	clear	clear	I-NP	JJ	O	6	NMOD	-1
3	cell	cell	I-NP	NN	O	6	NMOD	-1
4	renal	renal	I-NP	JJ	O	6	NMOD	-1
5	cell	cell	I-NP	NN	O	6	NMOD	-1
6	carcinoma	carcinoma	I-NP	NN	O	7	SUB	-1
7	has	have	B-VP	VBZ	O	0	ROOT	-1
8	a	a	B-NP	DT	O	11	NMOD	-1
9	higher	high	I-NP	JJR	O	11	NMOD	-1
10	angiogenic	angiogenic	I-NP	JJ	O	11	NMOD	3	angiogenic
11	activity	activity	I-NP	NN	O	7	OBJ	0
12	than	than	B-PP	IN	O	11	NMOD	-1
13	low-grade	low-grade	B-NP	JJ	O	16	NMOD	-1
14	renal	renal	I-NP	JJ	O	16	NMOD	-1
15	cell	cell	I-NP	NN	O	16	NMOD	-1
16	carcinoma	carcinoma	I-NP	NN	O	12	PMOD	-1
17	based	base	B-VP	VBN	O	16	NMOD	-1
18	on	on	B-PP	IN	O	17	VMOD	-1
19	histomorphological	histomorphological	B-NP	JJ	O	20	NMOD	-1
20	quantification	quantification	I-NP	NN	O	25	NMOD	-1
21	and	and	I-NP	CC	O	25	NMOD	-1
22	qRT-PCR	qRT-PCR	I-NP	NN	B-RNA	25	NMOD	-1
23	mRNA	mRNA	I-NP	NN	I-RNA	25	NMOD	0
24	expression	expression	I-NP	NN	O	25	NMOD	0
25	profile	profile	I-NP	NN	O	18	PMOD	-1
26	.	.	O	.	O	7	P	-1

1	Clear	Clear	B-NP	JJ	O	5	NMOD	-1
2	cell	cell	I-NP	NN	O	5	NMOD	-1
3	renal	renal	I-NP	JJ	O	5	NMOD	-1
4	cell	cell	I-NP	NN	O	5	NMOD	-1
5	carcinoma	carcinoma	I-NP	NN	O	9	SUB	-1
6	(	(	O	(	O	8	DEP	-1
7	CC-RCC	CC-RCC	B-NP	NN	O	8	DEP	-1
8	)	)	O	)	O	5	NMOD	-1
9	is	be	B-VP	VBZ	O	0	ROOT	-1
10	a	a	B-NP	DT	O	13	NMOD	-1
11	highly	highly	I-NP	RB	O	12	AMOD	-1
12	vascularised	vascularise	I-NP	VBN	O	13	NMOD	-1
13	tumour	tumour	I-NP	NN	O	9	PRD	-1
14	and	and	O	CC	O	9	VMOD	-1
15	is	be	B-VP	VBZ	O	9	VMOD	-1
16	therefore	therefore	B-ADVP	RB	O	15	VMOD	-1
17	an	an	B-NP	DT	O	19	NMOD	-1
18	attractive	attractive	I-NP	JJ	O	19	NMOD	-1
19	disease	disease	I-NP	NN	O	15	PRD	-1
20	to	to	B-VP	TO	O	21	VMOD	-1
21	study	study	I-VP	VB	O	19	NMOD	-1
22	angiogenesis	angiogenesis	B-NP	NN	O	21	OBJ	3	angiogenesis
23	and	and	O	CC	O	21	VMOD	-1
24	to	to	B-VP	TO	O	25	VMOD	-1
25	test	test	I-VP	VB	O	21	VMOD	-1
26	novel	novel	B-NP	JJ	O	28	NMOD	-1
27	angiogenesis	angiogenesis	I-NP	NN	O	28	NMOD	3	angiogenesis
28	inhibitors	inhibitor	I-NP	NNS	O	25	OBJ	-1
29	in	in	B-PP	IN	O	28	NMOD	-1
30	early	early	B-NP	JJ	O	32	NMOD	-1
31	clinical	clinical	I-NP	JJ	O	32	NMOD	-1
32	development	development	I-NP	NN	O	29	PMOD	0
33	.	.	O	.	O	9	P	-1

1	Endothelial	Endothelial	B-NP	JJ	B-cell_type	3	NMOD	-1
2	cell	cell	I-NP	NN	I-cell_type	3	NMOD	-1
3	proliferation	proliferation	I-NP	NN	O	4	SUB	1	proliferation
4	plays	play	B-VP	VBZ	O	0	ROOT	-1
5	a	a	B-NP	DT	O	7	NMOD	-1
6	pivotal	pivotal	I-NP	JJ	O	7	NMOD	-1
7	role	role	I-NP	NN	O	4	OBJ	0
8	in	in	B-PP	IN	O	4	VMOD	-1
9	the	the	B-NP	DT	O	10	NMOD	-1
10	process	process	I-NP	NN	O	8	PMOD	-1
11	of	of	B-PP	IN	O	10	NMOD	-1
12	angiogenesis	angiogenesis	B-NP	NN	O	11	PMOD	3	angiogenesis
13	.	.	O	.	O	4	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	aim	aim	I-NP	NN	O	6	SUB	-1
3	of	of	B-PP	IN	O	2	NMOD	-1
4	this	this	B-NP	DT	O	5	NMOD	-1
5	study	study	I-NP	NN	O	3	PMOD	-1
6	was	be	B-VP	VBD	O	0	ROOT	-1
7	to	to	B-VP	TO	O	8	VMOD	-1
8	compare	compare	I-VP	VB	O	6	PRD	-1
9	angiogenesis	angiogenesis	B-NP	NN	O	10	NMOD	3	angiogenesis
10	parameters	parameter	I-NP	NNS	O	8	OBJ	-1
11	in	in	B-PP	IN	O	10	NMOD	-1
12	low	low	B-NP	JJ	O	14	NMOD	-1
13	nuclear	nuclear	I-NP	JJ	O	14	NMOD	-1
14	grade	grade	I-NP	NN	O	11	PMOD	-1
15	(	(	O	(	O	17	DEP	-1
16	n=87	n=87	B-NP	NN	O	17	DEP	-1
17	)	)	O	)	O	14	NMOD	-1
18	vs	vs	B-PP	IN	O	14	NMOD	-1
19	high	high	B-NP	JJ	O	22	NMOD	-1
20	nuclear	nuclear	I-NP	JJ	O	22	NMOD	-1
21	grade	grade	I-NP	NN	O	22	NMOD	-1
22	CC-RCC	CC-RCC	I-NP	NN	O	18	PMOD	-1
23	(	(	O	(	O	25	DEP	-1
24	n=63	n=63	B-NP	NN	B-protein	25	DEP	-1
25	)	)	O	)	O	22	NMOD	-1
26	.	.	O	.	O	6	P	-1

1	A	A	B-NP	DT	O	2	NMOD	-1
2	panel	panel	I-NP	NN	O	5	SUB	-1
3	of	of	B-PP	IN	O	2	NMOD	-1
4	antibodies	antibody	B-NP	NNS	B-protein	3	PMOD	-1
5	was	be	B-VP	VBD	O	0	ROOT	-1
6	used	use	I-VP	VBN	O	5	VC	0
7	for	for	B-PP	IN	O	6	VMOD	-1
8	immunohistochemistry	immunohistochemistry	B-NP	NN	O	7	PMOD	-1
9	:	:	O	:	O	5	P	-1
10	CD34/Ki-67	CD34/Ki-67	B-NP	JJ	O	12	AMOD	-1
11	,	,	I-NP	,	O	10	P	-1
12	carbonic	carbonic	I-NP	JJ	O	17	NMOD	-1
13	anhydrase	anhydrase	I-NP	NN	O	17	NMOD	-1
14	IX	IX	I-NP	CD	O	13	NMOD	-1
15	,	,	O	,	O	17	P	-1
16	hypoxia-inducible	hypoxia-inducible	B-NP	JJ	O	17	NMOD	-1
17	factor-1alpha	factor-1alpha	I-NP	NN	O	25	NMOD	-1
18	(	(	O	(	O	20	DEP	-1
19	HIF-1alpha	HIF-1alpha	B-NP	NN	B-protein	20	DEP	-1
20	)	)	O	)	O	17	NMOD	-1
21	and	and	O	CC	O	25	NMOD	-1
22	vascular	vascular	B-NP	JJ	B-protein	25	NMOD	-1
23	endothelial	endothelial	I-NP	JJ	I-protein	25	NMOD	-1
24	growth	growth	I-NP	NN	I-protein	25	NMOD	0
25	factor	factor	I-NP	NN	I-protein	5	VMOD	-1
26	(	(	O	(	O	28	DEP	-1
27	VEGF	VEGF	B-NP	NN	B-protein	28	DEP	-1
28	)	)	O	)	O	25	NMOD	-1
29	.	.	O	.	O	5	P	-1

1	Vessel	Vessel	B-NP	NN	O	2	NMOD	-1
2	density	density	I-NP	NN	O	13	NMOD	-1
3	(	(	O	(	O	8	DEP	-1
4	MVD	MVD	B-NP	NN	O	7	NMOD	-1
5	-	-	B-NP	HYPH	O	7	P	-1
6	microvessel	microvessel	I-NP	NN	O	7	NMOD	-1
7	density	density	I-NP	NN	O	8	DEP	-1
8	)	)	O	)	O	2	NMOD	-1
9	,	,	O	,	O	13	P	-1
10	endothelial	endothelial	B-NP	JJ	B-cell_type	13	NMOD	-1
11	cell	cell	I-NP	NN	I-cell_type	13	NMOD	-1
12	proliferation	proliferation	I-NP	NN	O	13	NMOD	1	proliferation
13	fraction	fraction	I-NP	NN	O	22	NMOD	-1
14	(	(	O	(	O	17	DEP	-1
15	ECP	ECP	B-NP	NN	O	16	NMOD	-1
16	%	%	I-NP	NN	O	17	DEP	-1
17	)	)	O	)	O	13	NMOD	-1
18	and	and	O	CC	O	22	NMOD	-1
19	tumour	tumour	B-NP	NN	B-cell_type	22	NMOD	-1
20	cell	cell	I-NP	NN	I-cell_type	22	NMOD	-1
21	proliferation	proliferation	I-NP	NN	O	22	NMOD	1	proliferation
22	fraction	fraction	I-NP	NN	O	27	SUB	-1
23	(	(	O	(	O	26	DEP	-1
24	TCP	TCP	B-NP	NN	O	25	NMOD	-1
25	%	%	I-NP	NN	O	26	DEP	-1
26	)	)	O	)	O	22	NMOD	-1
27	were	be	B-VP	VBD	O	0	ROOT	-1
28	assessed	assess	I-VP	VBN	O	27	VC	-1
29	.	.	O	.	O	27	P	-1

1	mRNA	mRNA	B-NP	NN	B-RNA	3	NMOD	0
2	expression	expression	I-NP	NN	O	3	NMOD	0
3	levels	level	I-NP	NNS	O	9	SUB	-1
4	of	of	B-PP	IN	O	3	NMOD	-1
5	angiogenesis	angiogenesis	B-NP	NN	O	6	NMOD	3	angiogenesis
6	stimulators	stimulator	I-NP	NNS	O	8	NMOD	-1
7	and	and	I-NP	CC	O	8	NMOD	-1
8	inhibitors	inhibitor	I-NP	NNS	O	4	PMOD	-1
9	were	be	B-VP	VBD	O	0	ROOT	-1
10	determined	determine	I-VP	VBN	O	9	VC	-1
11	by	by	B-PP	IN	O	10	VMOD	-1
12	quantitative	quantitative	B-NP	JJ	O	13	NMOD	-1
13	RT-PCR	RT-PCR	I-NP	NN	O	11	PMOD	-1
14	.	.	O	.	O	9	P	-1

1	High-grade	High-grade	B-NP	JJ	O	2	NMOD	-1
2	CC-RCC	CC-RCC	I-NP	NN	O	3	SUB	-1
3	showed	show	B-VP	VBD	O	0	ROOT	-1
4	a	a	B-NP	DT	O	7	NMOD	-1
5	higher	high	I-NP	JJR	O	7	NMOD	-1
6	ECP	ECP	I-NP	NN	O	7	NMOD	-1
7	%	%	I-NP	NN	O	24	NMOD	-1
8	(	(	O	(	O	10	DEP	-1
9	P=0.049	P=0.049	B-NP	NN	O	10	DEP	-1
10	)	)	O	)	O	7	NMOD	-1
11	,	,	O	,	O	24	P	-1
12	a	a	B-NP	DT	O	24	NMOD	-1
13	higher	high	I-NP	JJR	O	24	NMOD	-1
14	TCP	TCP	I-NP	NN	O	24	NMOD	-1
15	%	%	I-NP	NN	O	14	NMOD	-1
16	(	(	O	(	O	18	DEP	-1
17	P=0.009	P=0.009	B-NP	NN	O	18	DEP	-1
18	)	)	O	)	O	15	NMOD	-1
19	,	,	O	,	O	24	P	-1
20	a	a	B-NP	DT	O	24	NMOD	-1
21	higher	high	I-NP	JJR	O	24	NMOD	-1
22	VEGF	VEGF	I-NP	NN	O	24	NMOD	-1
23	protein	protein	I-NP	NN	O	24	NMOD	-1
24	expression	expression	I-NP	NN	O	34	NMOD	9	expression
25	(	(	O	(	O	30	DEP	-1
26	P	P	B-NP	NN	O	30	DEP	-1
27	less	less	B-ADJP	JJR	O	26	NMOD	-1
28	than	than	B-PP	IN	O	27	AMOD	-1
29	0.001	0.001	B-NP	CD	O	28	PMOD	-1
30	)	)	O	)	O	24	NMOD	-1
31	,	,	O	,	O	34	P	-1
32	a	a	B-NP	DT	O	34	NMOD	-1
33	lower	low	I-NP	JJR	O	34	NMOD	-1
34	MVD	MVD	I-NP	NN	O	46	NMOD	-1
35	(	(	O	(	O	40	DEP	-1
36	P	P	B-NP	NN	O	40	DEP	-1
37	less	less	B-ADJP	JJR	O	36	NMOD	-1
38	than	than	B-PP	IN	O	37	AMOD	-1
39	0.001	0.001	B-NP	CD	O	38	PMOD	-1
40	)	)	O	)	O	34	NMOD	-1
41	and	and	O	CC	O	46	NMOD	-1
42	a	a	B-NP	DT	O	46	NMOD	-1
43	lower	low	I-NP	JJR	O	46	NMOD	-1
44	HIF-1alpha	HIF-1alpha	I-NP	NN	O	46	NMOD	-1
45	protein	protein	I-NP	NN	O	46	NMOD	-1
46	expression	expression	I-NP	NN	O	3	OBJ	9	expression
47	(	(	O	(	O	49	DEP	-1
48	P=0.002	P=0.002	B-NP	NN	O	49	DEP	-1
49	)	)	O	)	O	46	NMOD	-1
50	than	than	B-PP	IN	O	46	NMOD	-1
51	low-grade	low-grade	B-NP	JJ	O	52	NMOD	-1
52	CC-RCC	CC-RCC	I-NP	NN	O	50	PMOD	-1
53	.	.	O	.	O	3	P	-1

1	Growth	Growth	B-NP	NN	B-RNA	4	NMOD	0
2	factor	factor	I-NP	NN	I-RNA	4	NMOD	-1
3	mRNA	mRNA	I-NP	NN	I-RNA	4	NMOD	0
4	expression	expression	I-NP	NN	O	5	NMOD	0
5	analyses	analysis	I-NP	NNS	O	6	SUB	-1
6	revealed	reveal	B-VP	VBD	O	0	ROOT	-1
7	a	a	B-NP	DT	O	9	NMOD	-1
8	higher	high	I-NP	JJR	O	9	NMOD	-1
9	expression	expression	I-NP	NN	O	6	OBJ	10	expression
10	of	of	B-PP	IN	O	9	NMOD	-1
11	angiopoietin	angiopoietin	B-NP	NN	B-protein	10	PMOD	-1
12	2	2	I-NP	CD	I-protein	11	NMOD	-1
13	in	in	B-PP	IN	O	9	NMOD	-1
14	low-grade	low-grade	B-NP	JJ	O	15	NMOD	-1
15	CC-RCC	CC-RCC	I-NP	NN	O	13	PMOD	-1
16	.	.	O	.	O	6	P	-1

1	Microvessel	Microvessel	B-NP	NN	O	2	NMOD	-1
2	density	density	I-NP	NN	O	6	SUB	-1
3	and	and	O	CC	O	5	NMOD	-1
4	ECP	ECP	B-NP	NN	O	5	NMOD	-1
5	%	%	I-NP	NN	O	2	NMOD	-1
6	were	be	B-VP	VBD	O	0	ROOT	-1
7	inversely	inversely	I-VP	RB	O	6	VMOD	-1
8	correlated	correlate	I-VP	VBN	O	6	VC	-1
9	(	(	O	(	O	13	DEP	-1
10	Rho=-0.26	Rho=-0.26	B-NP	NN	B-protein	12	NMOD	-1
11	,	,	O	,	O	12	P	-1
12	P=0.001	P=0.001	B-NP	NN	O	13	DEP	-1
13	)	)	O	)	O	8	VMOD	-1
14	.	.	O	.	O	6	P	-1

1	Because	Because	B-PP	IN	O	16	VMOD	-1
2	of	of	I-PP	IN	O	1	PMOD	-1
3	the	the	B-NP	DT	O	5	NMOD	-1
4	imperfect	imperfect	I-NP	JJ	O	5	NMOD	-1
5	association	association	I-NP	NN	O	1	PMOD	0
6	of	of	B-PP	IN	O	5	NMOD	-1
7	nuclear	nuclear	B-NP	JJ	O	8	NMOD	-1
8	grade	grade	I-NP	NN	O	13	NMOD	-1
9	and	and	I-NP	CC	O	13	NMOD	-1
10	ECP	ECP	I-NP	NN	O	11	NMOD	-1
11	%	%	I-NP	NN	O	13	NMOD	-1
12	or	or	I-NP	CC	O	13	NMOD	-1
13	MVD	MVD	I-NP	NN	B-protein	6	PMOD	-1
14	,	,	O	,	O	16	P	-1
15	CC-RCC	CC-RCC	B-NP	NN	O	16	SUB	-1
16	was	be	B-VP	VBD	O	0	ROOT	-1
17	also	also	I-VP	RB	O	16	VMOD	-1
18	grouped	group	I-VP	VBN	O	16	VC	-1
19	based	base	B-PP	VBN	O	18	VMOD	-1
20	on	on	B-PP	IN	O	19	PMOD	-1
21	low/high	low/high	B-NP	JJ	O	22	NMOD	-1
22	MVD	MVD	I-NP	NN	O	20	PMOD	-1
23	and	and	I-NP	CC	O	25	NMOD	-1
24	ECP	ECP	I-NP	NN	O	25	NMOD	-1
25	%	%	I-NP	NN	O	22	NMOD	-1
26	.	.	O	.	O	16	P	-1

1	This	This	B-NP	DT	O	2	NMOD	-1
2	analysis	analysis	I-NP	NN	O	3	SUB	-1
3	revealed	reveal	B-VP	VBD	O	0	ROOT	-1
4	a	a	B-NP	DT	O	6	NMOD	-1
5	higher	high	I-NP	JJR	O	6	NMOD	-1
6	expression	expression	I-NP	NN	O	3	OBJ	9	expression
7	of	of	B-PP	IN	O	6	NMOD	-1
8	vessel	vessel	B-NP	NN	O	9	NMOD	-1
9	maturation	maturation	I-NP	NN	O	12	NMOD	2	maturation
10	and	and	O	CC	O	12	NMOD	-1
11	stabilisation	stabilisation	B-NP	NN	B-protein	12	NMOD	-1
12	factors	factor	I-NP	NNS	I-protein	7	PMOD	-1
13	(	(	O	(	O	22	DEP	-1
14	placental	placental	B-NP	JJ	B-protein	16	NMOD	-1
15	growth	growth	I-NP	NN	I-protein	16	NMOD	0
16	factor	factor	I-NP	NN	I-protein	20	NMOD	-1
17	,	,	O	,	O	20	P	-1
18	PDGFB1	PDGFB1	B-NP	NN	B-protein	20	NMOD	-1
19	,	,	O	,	O	20	P	-1
20	angiopoietin	angiopoietin	B-NP	NN	B-protein	22	DEP	-1
21	1	1	I-NP	CD	I-protein	20	NMOD	-1
22	)	)	O	)	O	12	NMOD	-1
23	in	in	B-PP	IN	O	6	NMOD	-1
24	CC-RCC	CC-RCC	B-NP	NN	O	23	PMOD	-1
25	with	with	B-PP	IN	O	6	NMOD	-1
26	high	high	B-NP	JJ	O	27	NMOD	-1
27	MVD	MVD	I-NP	NN	O	30	NMOD	-1
28	,	,	O	,	O	30	P	-1
29	a	a	B-NP	DT	O	30	NMOD	-1
30	group	group	I-NP	NN	O	25	PMOD	-1
31	of	of	B-PP	IN	O	30	NMOD	-1
32	CC-RCC	CC-RCC	B-NP	NN	O	31	PMOD	-1
33	highly	highly	B-VP	RB	O	34	VMOD	-1
34	enriched	enrich	I-VP	VBN	O	32	NMOD	-1
35	in	in	B-PP	IN	O	34	VMOD	-1
36	low	low	B-NP	JJ	O	39	NMOD	-1
37	nuclear	nuclear	I-NP	JJ	O	39	NMOD	-1
38	grade	grade	I-NP	NN	O	39	NMOD	-1
39	CC-RCC	CC-RCC	I-NP	NN	O	35	PMOD	-1
40	,	,	O	,	O	6	P	-1
41	with	with	B-PP	IN	O	6	NMOD	-1
42	low	low	B-NP	JJ	O	44	NMOD	-1
43	ECP	ECP	I-NP	NN	O	44	NMOD	-1
44	%	%	I-NP	NN	O	41	PMOD	-1
45	.	.	O	.	O	3	P	-1

1	Our	Our	B-NP	PRP$	O	2	NMOD	-1
2	results	result	I-NP	NNS	O	3	SUB	0
3	suggest	suggest	B-VP	VBP	O	0	ROOT	-1
4	heterogeneity	heterogeneity	B-NP	NN	O	3	OBJ	-1
5	in	in	B-PP	IN	O	4	NMOD	-1
6	angiogenic	angiogenic	B-NP	JJ	O	7	NMOD	3	angiogenic
7	activity	activity	I-NP	NN	O	10	NMOD	0
8	and	and	O	CC	O	10	NMOD	-1
9	vessel	vessel	B-NP	NN	O	10	NMOD	-1
10	maturation	maturation	I-NP	NN	O	5	PMOD	2	maturation
11	of	of	B-PP	IN	O	10	NMOD	-1
12	CC-RCC	CC-RCC	B-NP	NN	B-protein	11	PMOD	-1
13	,	,	O	,	O	4	P	-1
14	to	to	B-PP	TO	O	4	NMOD	-1
15	a	a	B-NP	DT	O	17	NMOD	-1
16	large	large	I-NP	JJ	O	17	NMOD	-1
17	extent	extent	I-NP	NN	O	14	PMOD	-1
18	linked	link	B-VP	VBN	O	17	NMOD	0
19	to	to	B-PP	TO	O	18	VMOD	-1
20	nuclear	nuclear	B-NP	JJ	O	21	NMOD	-1
21	grade	grade	I-NP	NN	O	19	PMOD	-1
22	,	,	O	,	O	14	P	-1
23	and	and	O	CC	O	14	PMOD	-1
24	,	,	O	,	O	14	P	-1
25	with	with	B-PP	IN	O	14	PMOD	-1
26	probable	probable	B-NP	JJ	O	28	NMOD	-1
27	therapeutic	therapeutic	I-NP	JJ	O	28	NMOD	-1
28	implications	implication	I-NP	NNS	O	25	PMOD	-1
29	.	.	O	.	O	3	P	-1

